| Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) JM Banales, V Cardinale, G Carpino, M Marzioni, JB Andersen, ... Nature reviews Gastroenterology & hepatology 13 (5), 261-80, 2016 | 1068 | 2016 |
| Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib E Herraez, E Lozano, RIR Macias, J Vaquero, L Bujanda, JM Banales, ... Hepatology 58 (3), 1065-1073, 2013 | 162 | 2013 |
| Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment A Nicolas-Boluda, J Vaquero, L Vimeux, T Guilbert, S Barrin, ... Elife 10, e58688, 2021 | 157 | 2021 |
| Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks J Vaquero, N Guedj, A Clapéron, THN Ho-Bouldoires, V Paradis, ... Journal of hepatology 66 (2), 424-441, 2017 | 138 | 2017 |
| Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition J Vaquero, MJ Monte, M Dominguez, J Muntané, JJG Marin Biochemical pharmacology 86 (7), 926-939, 2013 | 123 | 2013 |
| No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors P Martinez-Becerra, J Vaquero, MR Romero, E Lozano, C Anadon, ... Molecular Pharmaceutics 9 (6), 1693-1704, 2012 | 99 | 2012 |
| MicroRNA‐506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation O Erice, P Munoz‐Garrido, J Vaquero, MJ Perugorria, ... Hepatology 67 (4), 1420-1440, 2018 | 98 | 2018 |
| Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta AG Blazquez, O Briz, MR Romero, R Rosales, MJ Monte, J Vaquero, ... Molecular pharmacology 81 (2), 273-283, 2012 | 96 | 2012 |
| Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance J Vaquero, TH Nguyen Ho-Bouldoires, A Claperon, L Fouassier Oncogene 36 (22), 3067-3079, 2017 | 91 | 2017 |
| The IGF2/IR/IGF1R pathway in tumor cells and myofibroblasts mediates resistance to EGFR inhibition in cholangiocarcinoma J Vaquero, C Lobe, S Tahraoui, A Clapéron, M Mergey, F Merabtene, ... Clinical Cancer Research 24 (17), 4282-4296, 2018 | 84 | 2018 |
| Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins E Herraez, E Gonzalez-Sanchez, J Vaquero, MR Romero, MA Serrano, ... Molecular pharmaceutics 9 (9), 2565-2576, 2012 | 78 | 2012 |
| Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance L Fouassier, M Marzioni, MB Afonso, S Dooley, K Gaston, G Giannelli, ... Liver International 39, 43-62, 2019 | 68 | 2019 |
| Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology A Pellat, J Vaquero, L Fouassier Hepatology 67 (2), 762-773, 2018 | 67 | 2018 |
| Photothermal depletion of cancer-associated fibroblasts normalizes tumor stiffness in desmoplastic cholangiocarcinoma A Nicolás-Boluda, J Vaquero, G Laurent, G Renault, R Bazzi, ... ACS nano 14 (5), 5738-5753, 2020 | 65 | 2020 |
| Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds J Vaquero, O Briz, E Herraez, J Muntané, JJG Marin Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1833 (10), 2212-2219, 2013 | 59 | 2013 |
| Cancer-associated fibroblasts in cholangiocarcinoma J Vaquero, L Aoudjehane, L Fouassier Current opinion in gastroenterology 36 (2), 63-69, 2020 | 52 | 2020 |
| The TGF-β pathway: a pharmacological target in hepatocellular carcinoma? E Gonzalez-Sanchez, J Vaquero, MG Férnandez-Barrena, JJ Lasarte, ... Cancers 13 (13), 3248, 2021 | 46 | 2021 |
| Cold-atmospheric plasma induces tumor cell death in preclinical in vivo and in vitro models of human cholangiocarcinoma J Vaquero, F Judée, M Vallette, H Decauchy, A Arbelaiz, L Aoudjehane, ... Cancers 12 (5), 1280, 2020 | 45 | 2020 |
| Involvement of UDP-glucuronosyltransferases and sulfotransferases in the excretion and tissue distribution of resveratrol in mice M Böhmdorfer, A Szakmary, RH Schiestl, J Vaquero, J Riha, S Brenner, ... Nutrients 9 (12), 1347, 2017 | 45 | 2017 |
| FXR-dependent and-independent interaction of glucocorticoids with the regulatory pathways involved in the control of bile acid handling by the liver R Rosales, MR Romero, J Vaquero, MJ Monte, P Requena, ... Biochemical pharmacology 85 (6), 829-838, 2013 | 40 | 2013 |
